Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Benitec Biopharma (BNTC) Other Non Operating Income (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Other Non Operating Income for 7 consecutive years, with -$71000.0 as the latest value for Q2 2025.

  • Quarterly Other Non Operating Income fell 242.0% to -$71000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$71000.0 through Jun 2025, down 148.63% year-over-year, with the annual reading at -$71000.0 for FY2025, N/A changed from the prior year.
  • Other Non Operating Income hit -$71000.0 in Q2 2025 for Benitec Biopharma, down from $50000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $229000.0 in Q1 2022 to a low of -$507000.0 in Q3 2022.
  • Historically, Other Non Operating Income has averaged -$56833.3 across 5 years, with a median of -$34500.0 in 2023.
  • Biggest YoY gain for Other Non Operating Income was 380.0% in 2021; the steepest drop was 988.89% in 2021.
  • Year by year, Other Non Operating Income stood at $48000.0 in 2021, then rose by 4.17% to $50000.0 in 2022, then skyrocketed by 204.0% to $152000.0 in 2023, then plummeted by 67.11% to $50000.0 in 2024, then tumbled by 242.0% to -$71000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for BNTC at -$71000.0 in Q2 2025, $50000.0 in Q2 2024, and $152000.0 in Q4 2023.